A buyer proposes to acquire a Chinese company whose registered capital is RMB 50 million but only RMB 15 million has been paid. The old articles allow the remaining amount to be contributed years in the future. Under the revised Company Law and the 2024 transition rules, that historical timetable can become a live acquisition liability. The buyer needs to determine who will fund the gap, how the obligation affects price and whether capital reduction or seller contribution is more practical.
Article 47 of the revised Company Law establishes the modern five-year contribution framework for limited liability companies. Article 54 addresses accelerated contribution where the company cannot pay due debts, and Article 266 provides transition for legacy companies. The State Council's 2024 registered-capital provisions require certain companies established before July 1, 2024 with excessive remaining contribution periods to adjust them by June 30, 2027.
The specific issue
The Legal Rule
Under the revised Company Law and the 2024 transition rules, that historical timetable can become a live acquisition liability.
The Business Impact
Test the proposed structure against the actual operating scope before filing. Shareholding, capital, control rights and licences should be designed together; changing one later can trigger amendments, approvals or tax and governance consequences. Apply that to the facts of Unpaid Registered Capital in China M&A Before the 2027 Transition Deadline: Pricing the Liability and Drafting the SPA.
1. Identify whether the target falls within the legacy transition problem
Compare the target’s articles, subscription timeline and paid-in capital against the revised Company Law transition rules. Legacy companies with long or vague contribution schedules may face accelerated funding pressure before the 2027 transition endpoint. First identify whether the target is in that problem set before debating price mechanics.
2. Reconstruct contribution history from articles, bank records and shareholder documents
Reconstruct contribution history from articles of association, shareholder resolutions, bank receipts, capital-verification records and transfer agreements. Spreadsheet summaries are not evidence. Gaps between registered capital and verifiable paid-in amounts are the facts that drive SPA drafting.
3. Review non-cash contributions for legal transfer and valuation
Review non-cash contributions for actual title transfer, valuation basis and registration. Intellectual property, equipment or land-use rights that were never properly moved into the company leave both capital and asset holes. A capital account entry without transfer documents is not a completed contribution.
4. Trace historical equity transfers involving unpaid subscriptions
Trace equity transfers where sellers transferred unpaid subscription obligations. Buyers can inherit funding exposure if transfer documents and corporate approvals did not allocate the unpaid capital clearly. Historical secondary sales are often where unpaid-capital risk hides.
5. Test solvency because future dates may not eliminate accelerated funding risk
Test solvency and creditor position because a future contribution date may not prevent acceleration or creditor claims in distress scenarios. Do not assume that “not yet due” equals “no economic risk to the buyer after closing.”
6. Calculate the economic value of the buyer's future funding obligation
Model the cash the buyer must inject to satisfy unpaid registered capital, including timing, foreign-exchange steps and dilution if other shareholders fail to fund. That future funding is part of deal consideration even when the headline share price looks low.
7. Compare seller pre-closing contribution against a purchase-price reduction
Compare requiring the seller to complete contributions pre-closing against reducing the purchase price by the unpaid amount and funding post-closing. Each route has different creditor, FX and timing effects. Choose deliberately and document the economics in the term sheet.
8. Use escrow or holdback when the seller remains exposed to known capital claims
Where the seller remains exposed to known capital-related claims or incomplete contribution evidence, use escrow or holdback sized to that exposure. Closing without security against a seller who may disappear into enforcement difficulty leaves the buyer holding the operating company and the funding gap.
9. Consider capital reduction only after creditor and registration analysis
Consider capital reduction only after analyzing creditor notice, registration feasibility and commercial covenants. Reduction can shrink unpaid exposure but may trigger lender consent, incentive clawbacks or creditor objections. It is a project, not a clerical edit to the articles.
10. Review government incentive agreements tied to registered or paid-in capital
Review government incentives, grants and land arrangements tied to registered or paid-in capital thresholds. Changing capital figures to solve Company Law risk can jeopardize subsidies. Map incentive covenants before choosing remediation.
11. Review financing covenants before changing capital
Check loan agreements and security packages for covenants on capital, shareholding and further encumbrances. Capital remediation that breaches financing documents trades one legal problem for acceleration risk.
12. Map foreign-exchange and bank mechanics for a foreign post-closing shareholder
For foreign buyers, map SAFE/bank workflows, account opening and timing to inject capital after closing. A price model that assumes instant RMB funding can fail on banking mechanics even when the SPA is clear.
13. Draft capitalization representations covering the full historical record
Draft capitalization representations covering registered capital, paid-in amounts, contribution dates, non-cash valuations and historical transfers—not a one-line “capital is fully paid” warranty that the disclosure schedule then guts.
14. Use a specific indemnity instead of relying only on a general warranty
Use a specific unpaid-capital indemnity with defined covered claims, including creditor acceleration and regulatory remediation costs, rather than relying only on a general title warranty. Specificity improves recoverability and notice practice.
15. Make non-negotiable capital remediation a condition precedent
Where the buyer will not inherit unpaid funding risk, make completed contributions or a filed capital reduction a condition precedent with documentary proof. Soft seller promises to fund “as soon as possible” are not closing protection.
16. Create a detailed capital schedule attached to the SPA
Attach a capital schedule to the SPA listing each shareholder, subscribed amount, paid-in amount, form of contribution, due date and evidence reference. The schedule becomes the shared factual baseline for price, indemnity and post-closing funding.
17. Model a target with RMB50 million registered capital and only RMB15 million paid
Work a concrete model: for example, RMB50 million registered capital with only RMB15 million paid in. Show who must fund the RMB35 million, when, in what currency path and how the purchase price changes if the seller funds pre-closing versus the buyer funding post-closing. Abstract discussion underprices the issue.
18. Create a post-closing capital calendar with board oversight
After closing, maintain a board-supervised capital calendar with owners for bank filings, contribution deadlines and evidence retention. Unpaid capital risk does not end at signing; missed post-closing steps recreate the same exposure.
19. Run vendor diligence on capital before an auction process
In auction processes, run vendor diligence on capital early and issue a clean capital pack to bidders. Targets that force each buyer to reconstruct contribution history under time pressure produce uneven bids and late renegotiations.
20. Normalize the headline purchase price by adding required future capital funding
Normalize headline price by adding required future capital funding and related transaction costs. A low equity price plus a large unavoidable capital injection is not a bargain; it is a mislabeled total consideration.
Worked scenario: the headline price hides a future capital injection
Assume a foreign buyer agrees to pay RMB 90 million for all shares of a Nanjing industrial company. The target has RMB 50 million registered capital, of which only RMB 15 million has been paid. The old articles say the remaining RMB 35 million is due in 2034. The business is profitable, but it also has a bank loan requiring shareholder support and a local-government investment agreement that references registered and total investment.
If the buyer looks only at the equity price, it may underestimate the real acquisition cost. The revised Company Law and the State Council transition rules mean the old 2034 timetable cannot simply be assumed to remain untouched. The buyer must determine whether the contribution period needs adjustment and who will fund the RMB 35 million.
One option is to require the seller to contribute before closing. That gives the buyer a fully funded target but requires the seller to have cash and may change the company's balance sheet and deal economics. Another option is for the buyer to assume the future funding obligation and reduce the purchase price accordingly. A third is to reduce registered capital before closing, but that route requires creditor and contractual analysis and can affect the bank facility or investment incentives.
The SPA should state the answer expressly. The capitalization schedule should show registered capital, paid-in amount, unpaid amount, responsible shareholder and due date. Representations should cover historical contributions and prior equity transfers. A specific indemnity can address historical contribution defects, while escrow may be needed if the seller will leave China or otherwise be difficult to pursue.
The buyer should also normalize competing bids. A target priced at RMB 90 million with RMB 35 million of required future capital is economically different from a fully funded target priced at RMB 110 million. Investment committee materials should show the headline equity price and the normalized price after required capital funding.
The central lesson is that unpaid subscribed capital is both a legal liability and a pricing input. It should be solved in the financial model and the SPA at the same time.
Action checklist before implementation
- Confirm who has authority to choose pre-closing funding, price reduction or capital reduction.
- Assemble the core evidence set: articles, capital schedule, bank receipts, non-cash contribution files, transfer agreements, creditor position and financing covenants.
- Identify the one capital fact that most changes deal economics and verify it first.
- Quantify the buyer’s future funding obligation and FX path.
- List third parties whose consent is needed—creditors, lenders, incentive authorities or SAFE/bank channels.
- Define the fallback if seller funding or reduction cannot be completed pre-closing.
- Reconcile headline price with normalized capital-adjusted consideration.
- Assign owners for schedule evidence and remediation steps.
- Ensure SPA representations match the capital schedule.
- Retain a post-closing capital calendar with board oversight.
Quality-control questions
Before the matter is closed, an independent reviewer should be able to reconstruct paid-in versus registered capital, the chosen remediation route and the normalized deal consideration. The reviewer should explain why the team avoided pricing shares without treating future capital funding as part of total cost. If that explanation depends on recollection rather than the file, the work is not complete.
Decision tree for allocating the capital gap
The buyer should first determine whether the unpaid capital is legally due under the current and transitional framework and whether the target's financial condition creates accelerated funding pressure. If the company has overdue debts, litigation or weak cash flow, the buyer should not treat a distant contribution date as reliable simply because it appears in old articles.
Next, the buyer should compare three economic structures. Under seller funding, the seller contributes before closing and the buyer acquires a more fully funded balance sheet. Under buyer funding, the buyer assumes the future contribution and the equity price should be reduced accordingly. Under capital reduction, the company attempts to align registered capital with actual business needs, but creditor procedure, bank covenants and government commitments must be checked first.
The buyer should also trace historic equity transfers. If the current seller acquired shares from earlier shareholders before contributions were fully paid, counsel should determine what contractual and statutory obligations may remain relevant. A current capitalization table is not a substitute for the contribution history.
Foreign buyers should map the practical funding route as well. A promise to contribute after closing is only useful if the foreign shareholder can complete the necessary corporate, bank and foreign-exchange steps on the required timetable.
SPA drafting architecture
The SPA should contain a capitalization schedule showing registered capital, paid-in capital, unpaid amount, contribution form and due date. The representation should cover historical contributions, prior transfers and non-cash assets, not merely state that the register is accurate.
If seller funding is required, evidence of contribution should be a closing deliverable. If the buyer assumes the obligation, the purchase-price clause should state the economic adjustment. If there is uncertainty about historic liability, a specific indemnity can cover creditor claims, penalties or contribution demands tied to pre-closing facts.
Escrow or holdback may be appropriate where the seller's ability to satisfy a later indemnity is uncertain. The amount should be connected to the identified exposure rather than chosen arbitrarily. A general warranty cap may be inadequate for a known capital issue.
Finally, the deal timetable should identify the June 30, 2027 transition milestone where relevant. If signing and closing occur around that period, the documents should state which party is responsible for any required amendment to the contribution schedule and what happens if the registry process is not completed by the long-stop date.
Questions the investment committee should require before approving the acquisition
The committee should receive a normalized acquisition cost, not only the seller's equity price. The model should show the cash purchase price, any seller contribution before closing, the buyer's expected post-closing capital injection, identified liabilities and the effect of a possible capital reduction. This makes competing transactions economically comparable.
The legal team should also state whether the unpaid contribution is merely future funding or whether there is evidence of a historical breach. If a prior shareholder missed an already-due contribution, the risk is different from a valid future obligation that is being transitioned under the new regime. The SPA protections should reflect that distinction.
Government and lender dependencies should be summarized separately. A capital reduction may trigger creditor rights, lender consent, incentive clawback or amendment of an investment agreement. If any of those effects could exceed the amount of capital being reduced, the apparent remediation may destroy value.
The closing memorandum should finally identify what the buyer will see in the public corporate records immediately after completion. If the deal assumes an amended contribution schedule, capital reduction or seller funding, those steps should be reflected in the relevant corporate documents and filings rather than left as private contractual promises.
Final pricing check
Before signing, finance and legal should reconcile the purchase price model with the capitalization schedule one final time. If the buyer's model assumes that the seller will fund part of the unpaid capital, the SPA should make that funding a measurable closing deliverable. If the buyer will fund it instead, the investment committee paper should show that amount as part of total acquisition cost. The legal and financial documents should therefore produce the same economic answer.
Conclusion
This issue should be managed as a specific legal-control problem. The legal framework must be applied to verified facts and converted into an executable sequence. The central lesson from this scenario is to avoid pricing the shares without treating future capital funding as an economic part of the acquisition cost. A strong file shows the legal rule, the commercial decision, the supporting evidence and the fallback if the preferred route fails.
Legal and regulatory sources
[1] Company Law of the PRC (2023 Revision): https://www.npc.gov.cn/npc/c2/c30834/202312/t20231229_433999.html [2] State Council Provisions on Registered Capital Registration Management: https://xzfg.moj.gov.cn/front/law/detail?LawID=1727
This article is general legal information and is not legal advice for a specific matter.
Discussion
Share experience or questions about this topic. This is a public discussion — not legal advice. Do not post confidential case details.
Have a question after reading? Leave it here, or Ask a Lawyer for a free initial intake.
Comments are moderated. China Legal Portal is a directory and information resource; no attorney–client relationship is formed by posting here.
